엘앤케이바이오

156100KOSDAQ

56.8 / 100

Reference Date: 2026-09-08

Financial Score14.5 / 40

News Sentiment20.3 / 25

Momentum12.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 43.2% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Elan K Bio is a specialized medical device company focusing on the design, development, manufacturing, and sales of spinal implants used in orthopedic and neurosurgical procedures. Its products, classified as Class 3 medical devices, account for 95.9% of revenue generated primarily in the Americas.

Number of Employees

97people

Average Salary

60.4M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

2.94Industry Average 1.200.0Point

2.5x industry avg (risky)

ROE

-44.98Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

16.87Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20252.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲14.3% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼12.7% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -14.3% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 5Neutral 0Negative 0Average Sentiment Score 81

Positive
엘앤케이바이오, 태국 국제척추수술학회 참가…카데바 워크샵 실시
엘앤케이바이오의 국제척추수술학회 참가로 글로벌 시장 진출 기회 확대 및 기술 홍보 효과 기대.
Positive
엘앤케이바이오메드 ‘BluEX-C’ 美 FDA 추가 승인
엘앤케이바이오메드의 경추용 높이확장형 케이지 'BluEX-C'가 미국 FDA로부터 추가 승인을 받음으로써 시장 경쟁력 강화 및 매출 증대 기대.
Positive
美 의료진 요구한 ‘사이즈’ 추가?엘앤케이바이오 ‘BluEX-C’ F...
엘앤케이바이오의 새로운 척추 임플란트 'BluEX-C'가 다양한 척추 크기에 맞춘 풋프린트 사이즈 조절 기능을 도입하여 시장 경쟁력을 강화할 것으로 기대된다.

Detailed Momentum

52-week position1.0Point

Near 52w low (17%, downtrend)

Current 5,090Won52-week high 15,89052-week low 2,795

1-month return6.0Point

1m +43.18% (strong rise)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral타인에대한채무보증결정2026-08-24
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-20
Neutral전환가액의조정2026-08-19
Neutral반기보고서 (2026.06)2026-08-14
Neutral주식등의대량보유상황보고서(일반)2026-08-11